CVS Health Corporation declares quarterly dividend of $0.50 (50 cents) per share on its common stock

WOONSOCKET, R.I.y, 2018-Jan-02 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation’s common stock. The dividend is payable on February 2, 2018, to holders of record on January 24, 2018.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

SOURCE CVS Health Corporation

Carolyn Castel
carolyn.castel@cvshealth.com

CVS Health Corporation to host Q3 2017 financial results conference call on Monday, November 6, 2017

WOONSOCKET, R.I., 2017-Oct-30 — /EPR Retail News/ — CVS Health Corporation (NYSE:CVS) will be holding a conference call on Monday, November 6, 2017, at 8:30 a.m. (ET) with analysts and investors to discuss its third quarter financial results.

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

SOURCE CVS Health Corporation

MEDIA CONTACT
Carolyn Castel
carolyn.castel@cvshealth.com

CVS Health Corporation declares quarterly dividend of $0.50 per share on its common stock

WOONSOCKET, R.I., 2017-Sep-20 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today (September 19, 2017) announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation’s common stock. The dividend is payable on November 3, 2017, to holders of record on October 24, 2017.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Mike McGuire
Senior Vice President
Investor Relations
(401) 770-4050

Media Contact:
Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717

Source: CVS Health

CVS Health Corporation announces quarterly dividend of $0.50 (50 cents) per share on its common stock

WOONSOCKET, R.I., 2017-Jul-08 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today (July 6, 2017) announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation’s common stock. The dividend is payable on August 3, 2017, to holders of record on July 24, 2017.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Nancy Christal
Senior Vice President
Investor Relations
(914) 722-470

Media Contact:

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717

Source: CVS Health

CVS Health Corporation to hold 4Q 2016 conference call on Thursday, February 9, 2017

WOONSOCKET, R.I., 2017-Jan-31 — /EPR Retail News/ — CVS Health Corporation (NYSE:CVS) will be holding a conference call on Thursday, February 9, 2017, at 8:30 a.m. (ET) with analysts and investors to discuss its fourth quarter financial results.

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contact:

Carolyn Castel
carolyn.castel@cvshealth.com

SOURCE: CVS Health Corporation

CVS Health Corporation to hold 3Q financial results conference call on Tuesday, November 8, 2016

WOONSOCKET, R.I., 2016-Oct-30 — /EPR Retail News/ — CVS Health Corporation (NYSE:CVS) will be holding a conference call on Tuesday, November 8, 2016, at 8:30 a.m. (ET) with analysts and investors to discuss its third quarter financial results.

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contact:

Carolyn Castel
carolyn.castel@cvshealth.com

SOURCE: CVS Health

CVS Health Corporation declares quarterly dividend of $0.425 (42.5 cents) per share

WOONSOCKET, R.I., 2016-Sep-23 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today ( Sept. 22, 2016) announced that its board of directors has approved a quarterly dividend of $0.425 (42.5 cents) per share on the corporation’s common stock. The dividend is payable on November 3, 2016, to holders of record on October 24, 2016.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health.  Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways.  This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.  Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Nancy Christal
Senior Vice President
Investor Relations
(914) 722-4704

Media Contact:

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717

SOURCE: CVS Health Corporation

CVS Health Corporation 2Q2016 conference call on Tuesday, August 2, 2016

WOONSOCKET, R.I., 2016-Jul-23 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) will be holding a conference call on Tuesday, August 2, 2016, at 8:30 a.m. (EDT) with analysts and investors to discuss its second quarter financial results.

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the website for a one-year period following the conference call.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Contact:

Carolyn Castel
carolyn.castel@cvshealth.com

SOURCE: CVS Health Corporation

CVS Health Corporation declares quarterly dividend of $0.425 per share on its common stock

WOONSOCKET, R.I., 2016-Jul-07 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today announced that its board of directors has approved a quarterly dividend of $0.425 (42.5 cents) per share on the corporation’s common stock. The dividend is payable on August 1, 2016, to holders of record on July 21, 2016.

About CVS Health

CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact

Nancy Christal
Senior Vice President
Investor Relations
(914) 722-4704

Media Contact

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717

Source: CVS Health

CVS Health Corporation commenced cash tender offers for its Senior Notes to refinance a portion of CVS Health’s outstanding indebtedness

WOONSOCKET, R.I., 2016-May-17 — /EPR Retail News/ — CVS Health Corporation (“CVS Health”, NYSE: CVS) announced today that it has commenced cash tender offers (the “Tender Offers”) for (1) any and all of its 5.75% Senior Notes due 2017, its 6.60% Senior Notes due 2019 and its 4.75% Senior Notes due 2020 (collectively, the “Any and All Notes”) and (2) up to $1,500,000,000 aggregate principal amount (the “Maximum Tender Offer Amount”) of its 6.25% Senior Notes due 2027, its 6.125% Senior Notes due 2039, its 5.750% Senior Notes due 2041, the 5.00% Senior Notes due 2024 (the “Omnicare 2024 Notes”) issued by its wholly-owned subsidiary, Omnicare, Inc. (“Omnicare”), the 4.75% Senior Notes due 2022 (the “Omnicare 2022 Notes”, and together with the Omnicare 2024 Notes, the “Omnicare Notes”) issued by Omnicare, its 4.875% Senior Notes due 2035 and its 3.875% Senior Notes due 2025 (collectively, the “Maximum Tender Offer Notes” and together with the Any and All Notes, the “Notes”). The Tender Offers are being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated May 16, 2016 (as amended or supplemented from time to time, the “Offer to Purchase”) and related Letter of Transmittal (the “Letter of Transmittal”). The Tender Offers are open to all registered holders (individually, a “Holder” and collectively, the “Holders”) of the Notes. The purpose of the Tender Offers is to refinance a portion of CVS Health’s outstanding indebtedness.

Notes validly tendered and not validly withdrawn at or prior to 5:00 p.m., New York City time, on May 27, 2016 (the “Early Tender Date”) will be eligible to receive the applicable Total Consideration (as defined in the Offer to Purchase), which includes the applicable Early Tender Payment (as defined in the Offer to Purchase). The applicable Total Consideration per $1,000 principal amount of the 5.00% Senior Notes due 2024 and the 4.75% Senior Notes due 2022 issued by Omnicare will be the fixed amounts set forth in the table below. With regard to the other Notes, the applicable Total Consideration payable with respect to the Notes issued by CVS Health will be an amount based on the yield to maturity of the U.S. Treasury reference securities specified in the table below (the “UST Reference Security”), as determined at 11:00 a.m., New York City time, on May 27, 2016 (unless otherwise extended as described in the Offer to Purchase), plus a fixed spread, calculated in accordance with the Offer to Purchase.

Notes validly tendered after the Early Tender Date but at or prior to 11:59 p.m., New York City time, on June 13, 2016 (the “Expiration Date”) will be eligible to receive the applicable tender offer consideration (the “Tender Offer Consideration”), namely the applicable Total Consideration minus the applicable Early Tender Payment specified in the table below.

In addition to the Total Consideration or Tender Offer Consideration, as applicable, Holders of Notes accepted for purchase will receive accrued and unpaid interest on those Notes from the last interest payment date with respect to those Notes to, but not including, any Early Settlement Date (as defined in the Offer to Purchase, and which may occur as early as May 31, 2016) or the Final Settlement Date (as defined in the Offer to Purchase) and which is expected to occur on June 15, 2016, as applicable.

Certain details regarding the Tender Offers are set forth in the table below:
cvs-health-investor-table Tender Offers

Holders who tender their Notes at or prior to 5:00 p.m., New York City time, on May 27, 2016 (such date and time, as it may be extended, the “Withdrawal Deadline”) may withdraw such tendered Notes at any time at or prior to the Withdrawal Deadline. Following the Withdrawal Deadline, Holders who have tendered their Notes (whether before, on or after the Withdrawal Deadline) may not withdraw such Notes unless CVS Health is required to extend withdrawal rights under applicable law. Acceptance of tendered Maximum Tender Offer Notes will be purchased based on the acceptance priority levels applicable to the relevant series and may be subject to proration, in each case as described in the Offer to Purchase. CVS Health reserves the right, but is not obligated, to increase the Maximum Tender Offer Amount without extending withdrawal rights, subject to compliance with applicable law.

CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to terminate the Tender Offers at any time prior to the Expiration Date. The Tender Offers are not conditioned on any minimum principal amount of Notes being tendered but the Tender Offers are subject to a financing condition and certain other general conditions as described in the Offer to Purchase.

CVS Health has retained Barclays Capital Inc., J.P. Morgan Securities LLC and RBC Capital Markets, LLC to act as Dealer Managers for the Tender Offers. D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Tender Offers. For additional information regarding the terms of the Tender Offers, please contact the Dealer Managers at Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect), J.P. Morgan Securities LLC at (866) 834-4666 (toll-free) or (212) 834-3424 (collect), or RBC Capital Markets, LLC at (877) 381-2099 (toll-free) or (212) 618-7822 (collect). Requests for documents and questions regarding the tendering of Notes may be directed to D.F. King & Co., Inc. either by email at cvs@dfking.com, or by phone (212) 269-5550 (for banks and brokers only) or (866) 745-0265 (for all others toll free).

This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase and the related Letter of Transmittal made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all information in the Offer to Purchase and the related Letter of Transmittal, consult their own investment and tax advisers and make their own decisions whether to tender Notes in either Tender Offer, and, if so, the principal amount of Notes to tender.

About the Company
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,600 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 80 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in CVS Health’s Securities and Exchange Commission filings, including those set forth in the Risk Factors section in its Annual Report on Form 10-K for the year ended December 31, 2015.

SOURCE CVS Health Corporation

CVS Health Corporation president and CEO Larry Merlo to present at the 34th Annual J.P. Morgan Healthcare Conference on January 12, 2016

WOONSOCKET, R.I., 2016-1-4 — /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, the company’s president and chief executive officer, will be making a presentation to investors at the 34th Annual J.P. Morgan Healthcare Conference on January 12, 2016. He is scheduled to present at approximately 7:30 a.m. PT (10:30 a.m. ET).

An audio and video webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website for all interested parties, and will be archived and available for a one-year period. To access the webcast or an archive of the event, visit http://investors.cvshealth.com.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health.  Through our more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways.  This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.  Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

Investor Contact:

Nancy Christal
Senior Vice President
Investor Relations
(914) 722-4704

Media Contact:

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717

CVS Health completes the acquisition of Target’s pharmacy and clinic businesses for approximately $1.9 billion

Woonsocket, RI and Minneapolis, MN, 2015-12-17 — /EPR Retail News/ — CVS Health Corporation (NYSE:CVS) and Target Corporation (NYSE:TGT) announced today that CVS Health has completed the acquisition of Target’s pharmacy and clinic businesses for approximately $1.9 billion. With the completion of the transaction, CVS Health acquired Target’s 1,672 pharmacies across 47 states and will operate them through a store-within-a-store format, branded as CVS/pharmacy. In addition, a CVS/pharmacy will be included in all new Target stores that offer pharmacy services. Seventy-nine Target clinic locations will be rebranded as MinuteClinic, and CVS Health will open up to 20 new clinics in Target stores within three years of the close of the transaction.

“We look forward to helping Target guests on their path to better health through CVS Health’s leading clinical programs, such as Maintenance Choice, Pharmacy Advisor and Specialty Connect,” said Larry Merlo, CVS Health President and CEO. “In addition, with the Target acquisition we will leverage our unique integrated business model and our scale to drive incremental sales volume and operating profit for the enterprise while providing convenience and cost savings to consumers and payors.”

“Today’s milestone in our relationship with CVS Health is an important step in driving Target’s strategic priorities forward while giving our guests easy access to industry-leading health care services. With the transition now underway, Target can further accelerate our commitment to Wellness as a signature category, helping guests and team members in their efforts to eat better, be more active and find natural and clean label products,” said Brian Cornell, Chairman and CEO of Target.

The Target pharmacies and clinics will be transitioned to the CVS Health banners and systems within six to eight months.

Financial Considerations

The closing of this transaction is expected to have the following impact on Target’s fourth quarter 2015 financial results:

  • The recognition of a pre-tax gain of $575 million to $775 million, based on the final valuation of assets sold. The gain will be excluded from Adjusted Earnings per Share.
  • A reduction of expected fourth quarter sales of approximately $500 million, with no change to the company’s expected fourth quarter segment EBIT.

The closing of this transaction does not change Target’s expected fourth quarter comparable sales, because the comparable sales calculation will only include pharmacy sales from fourth quarter 2014 for the equivalent period in which Target operated its pharmacies in fourth quarter 2015.

Target’s after-tax net proceeds from the transaction are expected to be approximately $1.2 billion, which the company expects to deploy over time in support of its long-standing capital priorities, including share repurchase. This transaction is expected to be accretive to Target’s EBITDA and EBIT margin rates and add half a percentage point or more to Target’s return on invested capital over time.

CVS Health will discuss the acquisition in more detail at its Annual Analyst Day, which is being held today in New York City and simulcast on its website, at https://investors.cvshealth.com.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com.

About Target
Minneapolis-based Target Corporation (NYSE: TGT) serves guests at 1,805 stores and at Target.com. Since 1946, Target has given 5 percent of its profit to communities, which today equals more than $4 million a week. For more information, visit Target.com/Pressroom. For a behind-the-scenes look at Target, visit Target.com/abullseyeview or follow @TargetNews on Twitter.

CVS Health Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the federal securities laws.  By their nature, all forward-looking statements involve risks and uncertainties. Actual results may differ materially from those contemplated by the forward-looking statements for a number of reasons as described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the section entitled “Cautionary Statement Concerning Forward-Looking Statements” in our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

Target Forward-Looking Statements

Statements by Target in this release regarding Target’s expected after-tax proceeds from the transaction and the expected impact of the transaction on Target’s Segment Sales, EBITDA and EBIT margins, EPS and Adjusted EPS, and ROIC are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements speak only as of the date they are made and are subject to risks and uncertainties that could cause Target’s actual results to differ materially. The most important risks and uncertainties include those relating to how Target’s guests react to the transaction, the effectiveness of the ongoing relationship between Target and CVS Health, whether Target will recognize the expected benefits from the transaction and the risks described in Item 1A of Target’s Form 10-K for the fiscal year ended January 31, 2015.

Contacts:

For CVS Health:

Nancy Christal, Investor Relations, (401) 770-3614
Carolyn Castel, Corporate Communications, (401) 770-5717
Carolyn.Castel@CVSHealth.com

For Target:

John Hulbert, Investors, (612) 761-6627
Dustee Jenkins, Media, (612) 761-9537
Target Media Hotline, (612) 696-3400
press@target.com

SOURCE: CVS Health

CVS Health Corporation will hold its third quarter financial results conference call on October 30, 2015

WOONSOCKET, R.I., 2015-10-21 — /EPR Retail News/ — CVS Health Corporation (NYSE:CVS) will be holding a conference call on Friday, October 30, 2015, at 8:30 a.m. (EDT) with analysts and investors to discuss its third quarter financial results.

An audio webcast of the conference call will be broadcast simultaneously through the Investor Relations portion of the CVS Health website for all interested parties. To access the webcast, visit http://investors.cvshealth.com. This webcast will be archived and available on the web site for a one-year period following the conference call.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through our more than 7,800 retail pharmacies, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

MEDIA INQUIRIES

Carolyn Castel
1-401-770-5717
carolyn.castel@cvshealth.com

SOURCE: CVS Health Corporation

CVS Health Corporation commenced private exchange offers to Eligible Holders and Consent Solicitations

WOONSOCKET, R.I., 2015-9-23 — /EPR Retail News/ — CVS Health Corporation (“CVS Health”, NYSE:CVS) announced today that is has commenced (A) private exchange offers (“Exchange Offers”) to Eligible Holders (as defined below) to exchange new 4.75% Senior Notes due 2022 (the “New CVS Health 2022 Notes”) and new 5.00% Senior Notes due 2024 (the “New CVS Health 2024 Notes” and, together with the New CVS Health 2022 Notes, the “New CVS Health Notes”), in each case issued by CVS Health, and cash payments for the 4.75% Senior Notes due 2022 (the “Existing Omnicare 2022 Notes”) and the 5.00% Senior Notes due 2024 (the “Existing Omnicare 2024 Notes” and, together with the Existing Omnicare 2022 Notes, the “Existing Omnicare Notes”), in each case issued by Omnicare, Inc. (“Omnicare”), which was recently acquired by CVS Health, and (B) a solicitation of consents (the “Consent Solicitations”) from Eligible Holders of Existing Omnicare Notes to proposed amendments that would eliminate substantially all restrictive covenants and certain events of default and other provisions of the indentures under which such Existing Omnicare Notes were issued (the “Proposed Amendments”).

The consent of the Eligible Holders of a majority of the aggregate principal amount of the Existing Omnicare Notes outstanding of both series will be required in order to approve the Proposed Amendments for each series (the “Requisite Consents”). If the Requisite Consents are only obtained in respect of one series of Existing Omnicare Notes, CVS Health may, in its sole discretion, waive the requirement that the Requisite Consents be obtained in respect of both series of Existing Omnicare Notes and adopt the Proposed Amendments and consummate the Exchange Offer only in respect of such series of Existing Omnicare Notes for which Requisite Consents have been received.

Each Exchange Offer and Consent Solicitation will expire at 11:59 p.m., New York City time, on October 20, 2015, unless extended (as it may be extended, the “Expiration Date”).

For each $1,000 principal amount of Existing Omnicare Notes validly tendered at or prior to 5:00 p.m., New York City time, on October 5, 2015, unless extended (as it may be extended, the “Early Tender Date”) and not validly withdrawn, Eligible Holders of Existing Omnicare Notes will be eligible to receive the applicable total exchange consideration set out in the table below (the “Total Exchange Consideration”), which includes the applicable early tender premium set out in such table (the “Early Tender Premium”), on the Early Settlement Date, which is expected to be October 9, 2015.

For each $1,000 principal amount of Existing Omnicare Notes validly tendered after the Early Tender Date but prior to the Expiration Date and not validly withdrawn, Eligible Holders of Existing Omnicare Notes will be eligible to receive only the applicable Exchange Consideration set out in the table below.

Title of Series CUSIP Number Principal Amount Outstanding Exchange Consideration(1) Early Tender Premium(1) Total Exchange Consideration(1)(2)
4.75% Senior Notes due 2022 681904AS7 $400,000,000 $970 principal amount of New CVS Health 2022 Notes and $2.50
in cash
$30 principal amount of New CVS Health 2022 Notes $1,000 principal amount of New CVS Health 2022 Notes and $2.50 in cash
5.00% Senior Notes due 2024 681904AT5 $300,000,000 $970 principal amount of New CVS Health 2024 Notes and $2.50
in cash
$30 principal amount of New CVS Health 2024 Notes $1,000 principal amount of New CVS Health 2024 Notes and $2.50 in cash

 

(1)For each $1,000 principal amount of Existing Omnicare Notes, subject to any rounding as described in the Offering Memorandum (as defined below).

(2) Includes Early Tender Premium.

The New CVS Health Notes delivered in exchange for validly tendered Existing Omnicare Notes will bear interest from (and including) the most recent interest payment date on the Existing Omnicare Notes. No cash interest will be paid in connection with the Exchange Offers with respect to the Existing Omnicare Notes tendered for exchange in the Exchange Offers.

Tenders of Existing Omnicare Notes may be validly withdrawn at any time on or prior to 5:00 p.m., New York City time, on October 5, 2015, unless extended, except in certain limited circumstances as set forth in a confidential offering memorandum and consent solicitation statement dated September 22, 2015 (the “Offering Memorandum”).

The consummation of the Exchange Offers is subject to, and conditional upon, the satisfaction or, where permitted, waiver of certain conditions discussed in the Offering Memorandum.

The New CVS Health Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any other applicable securities laws and, unless so registered, the New CVS Health Notes may not be offered, sold, pledged or otherwise transferred within the United States or to or for the account or benefit of any U.S. person, except pursuant to an exemption from the registration requirements of the Securities Act. Accordingly, the Exchange Offers will only be made (i) to qualified institutional buyers pursuant to Rule 144A under the Securities Act and (ii) to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act (collectively, “Eligible Holders”).

The complete terms and conditions of the Exchange Offers and the Consent Solicitations, as well as the terms of the New CVS Health Notes, are set forth in the Offering Memorandum and a related letter of transmittal and consent. The Offering Memorandum and related letter of transmittal and consent will only be made available to holders who complete an eligibility letter confirming their status as Eligible Holders. Holders of Existing Omnicare Notes who wish to receive a copy of the eligibility letter for the Exchange Offers may contact D.F. King & Co., Inc. toll free at (800) 814-9324, (212) 269-5550 (banks and brokerage firms) or at www.dfking.com/Omnicare.

This press release does not constitute an offer to sell or a solicitation of any offer to buy any securities, nor shall there be any sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This press release is being issued pursuant to Rule 135c under the Securities Act.

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health. Through its more than 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, CVS Health enables people, businesses and communities to manage health in more effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.

Cautionary Statement Concerning Forward Looking Statements

This release contains certain “forward looking statements” within the meaning of the federal securities laws. In addition, the Company and its representatives may, from time to time, make written or verbal forward looking statements, including statements contained in the Company’s filings with the SEC and in its reports to stockholders, press releases, webcasts, conference calls, meetings and other communications. Generally, the inclusion of the words “believe,” “expect,” “intend,” “estimate,” “project,” “anticipate,” “will,” “should” and similar expressions identify statements that constitute forward looking statements. All statements addressing operating performance of CVS Health or any subsidiary, events or developments that the Company expects or anticipates will occur in the future, including statements relating to corporate strategy; revenue growth; earnings or earnings per common share growth; adjusted earnings or adjusted earnings per common share growth; free cash flow; debt ratings; inventory levels; inventory turn and loss rates; store development; relocations and new market entries; retail pharmacy business, sales trends and operations; pharmacy business management business, sales trends and operations; the Company’s ability to attract or retain customers and clients; Medicare Part D competitive bidding, enrollment and operations; new product development; and the impact of industry developments, as well as statements expressing optimism or pessimism about future operating results or events, are forward looking statements within the meaning of the federal securities laws.

The forward looking statements are and will be based upon management’s then current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. The Company undertakes no obligation to update or revise any forward looking statements, whether as a result of new information, future events, or otherwise.

SOURCE: CVS Health Corporation

CVS Health Corporation announces the completion of the acquisition of Omnicare for approximately $12.9 billion

WOONSOCKET, R.I., 2015-8-19— /EPR Retail News/ — CVS Health Corporation (NYSE: CVS) announced today that it has completed the acquisition of Omnicare, the leading provider of pharmacy services to long term care facilities, for a total enterprise value of approximately $12.9 billion.

About CVS Health
CVS Health (NYSE:  CVS) is a pharmacy innovation company helping people on their path to better health.  Through its 7,800 retail drugstores, nearly 1,000 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.  Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

Contacts:

Nancy Christal
Senior Vice President
Investor Relations
(914) 722-4704

Carolyn Castel
Vice President
Corporate Communications
(401) 770-5717
Carolyn.Castel@CVSHealth.com